DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20203706

Takayasu arteritis: a comprehensive review of literature

Ravin K. Bishnoi, Shivani Devi, Shivani Rai, Gunjot .

Abstract


Takayasu arteritis is an inflammatory pulseless disease of large arteries with unknown etiology which advances in three stages i.e. early systemic, vascular, and burnout stage. It is more prevalent in Asian women of childbearing age. Hypertension, fever, weight loss, arthralgia, limb claudication, light-headedness, and arterial pain are common manifestations. Angiography is a gold standard test to evaluate TA. There is no reliable serological marker has been identified. Control on the inflammatory process and hypertension are two imperative angles to treat the disease. Steroids are most used. Reconstructive surgeries are limited to severe and stenotic lesions. This review aims to report comprehensive evidence about Takayasu arteritis. We conducted an integrative review of theoretical and empirical publications reporting epidemiology, etiopathogenesis, classification, diagnostic evaluation, and management of TA. The authors searched PubMed, Embase, and Scopus until March 2020.  A total of 1104 records found, we included 37 papers for review after reading the articles. Remaining was excluded because of no innovative content, insufficient details, and no clear endpoints. This review of the literature presents comprehensive evidence in all fields of TA. Still, large areas need to be studied for better management of patients with TA.


Keywords


Aneurysms, Arteritis, Pulse, Pulseless disease, Takayasu’s

Full Text:

PDF

References


Vitthala S, Misra P. Takayasu’ s Arteritis and Pregnancy : A Review. Internet J Gynecol Obstet. 2007;9(2):1-5.

Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol [Internet]. 2002;55(7):481–6.

Singh N, Tyagi S, Tripathi R, Mala YM. Maternal and fetal outcomes in pregnant women with Takayasu aortoarteritis: Does optimally timed intervention in women with renal artery involvement improve pregnancy outcomes? Taiwan J Obstet Gynecol . 2015;54(5):597-602.

Alibaz-Oner F, Aydin SZ, Direskeneli H. Recent advances in Takayasu’s arteritis. Eur J Rheumatol. 2015;2(1):24-30.

Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu’s arteritis. Lancet. 2000;356(9234):1023-5.

Chugh KS, Jain S, Sakhuja V, Malik N, Gupta A, Gupta A, et al. Renovascular hypertension due to Takayasu’s arteritis among Indian patients. Q J Med. 2019;85(307,308):833-43.

Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med. 2017;46(7–8):e197-203.

Jain S, Pondaiah SK. Takayasu’s arteritis: Review of epidemiology and etiopathogenesis. Indian J Rheumatol, 2015;10:S22-9.

Parakh R, Yadav A. Takayasu’s Arteritis: An Indian Perspective. Eur J Vasc Endovasc Surg. 2007;33(5):578-82.

Seyahi E. Takayasu arteritis: An update. Curr Opin Rheumatol. 2017;29(1):51-6.

Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu’s disease). Circulation. 1989;80(3):429-37.

Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol. 1996;54:S111-6.

Espinoza J, Ai S, Matsumura I. New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens. 2018;7(3):73.

Serra R, Butrico L, Fugetto F, Chibireva MD, Malva A, De Caridi G, et al. Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Ann Vasc Surg. 2016;35:210-25.

Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu’s arteritis: A 2011 update. Autoimmun Rev.2011;11(1):61-7.

Sagar S, Ganguly NK, Koicha M, Sharma BK. Immunopathogenesis of Takayasu arteritis. Heart Vessels. 1992 Mar;7(S1):85-90.

Markel, Peter A; Matteson, Eric L; Curtis MR. Clinical features and diagnosis of Takayasu arteritis - UpToDate.2019

Maffei S, Di Renzo M, Bova G, Auteri A, Pasqui AL. Takayasu’s arteritis: a review of the literature. Intern Emerg Med. 2006;1(2):105-12.

Sadurska E, Jawniak R, Majewski M, Czekajska-Chehab E. Takayasu arteritis as a cause of arterial hypertension. Case report and literature review. Eur J Pediatr. 2012;171(5):863-9.

Li-xin Z, Jun N, Shan G, Bin P, Li-ying C. Neurological manifestations of Takayasu arteritis. Chinese Med Sci J = Chung-kuo i hsueh k’o hsueh tsa chih. 2011;26(4):227-30.

Kim HJ, Suh DC, Kim JK, Kim SJ, Lee JH, Choi CG, et al. Correlation of neurological manifestations of Takayasu’s arteritis with cerebral angiographic findings. Clin Imaging. 2005;29(2):79-85.

Setty NSN, Vijaykumar HS, Nagesh JR, Patil CM, Jadav SS, Raghu SR, et al. Takayasu’s arteritis-a comprehensive review. J Rare Dis Res Treat. 2017.2

Peter J, David S, Danda D, Peter JV, Horo S, Joseph G. Ocular manifestations of takayasu arteritis: A cross-sectional study. Retina. 2011;31(6):1170-8.

Chauhan A. Takayasu Arteritis-Ocular Perspectives. EC Ophthalmol. 2016;4(5):592–3.

Takayasu’s Arteritis : Johns Hopkins Vasculitis Center. https://www.hopkinsvasculitis.org/types-vasculitis/takayasus-arteritis/. Accessed on 10 June 2020.

Takayasu’s Arteritis - Vasculitis Foundation. https://www.vasculitisfoundation.org/education/forms/takayasus-arteritis/. Accessed on 10 June 2020.

Agarwal R, Sinha RK, Goel A, Lakhani KK, Aggarwal A. Takayasu’s arteritis. Journal, Indian Acad Clin Med. 2006;7(3):248-51.

Koga T, Nishino Y, Makiyama J, Hayashida T, Miyashita T, Izumi Y, et al. Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu’s arteritis. Rheumatol Int. 2010;30(4):561-3.

Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis: A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66:191-4.

Keser G, Aksu K, Direskeneli H. Takayasu arteritis: An update. Turkish J Med Sci. 2018;48(4):681-97.

Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid‐resistant or relapsing takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37(4):578-82.

Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu’s arteritis. J Rheumatol. 2003;30(8):1793-8.

Agueda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, Dasgupta B, et al. Management of Takayasu arteritis: A systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD Open. 2019;5(2):1-13.

Bali HK, Jain AK. Takayasu’s arteritis: Current status of angioplasty and stenting. Asian Cardiovasc Thorac Ann. 1999;7(4):339-44.

Weaver FA, Kumar SR, Yellin AE, Anderson S, Hood DB, Rowe VL, et al. Renal revascularization in Takayasu arteritis–induced renal artery stenosis. J Vasc Surg. 2004;39(4):749-57.

Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu’s arteritis. Circulation. 2003;108(12):1474-80.

Joh JH, Kim DK, Park KH, Kim DI. Surgical Management of Takayasu’s Arteritis. J Korean Med Sci. 2006;21(1):20-4.